{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:23:59Z","timestamp":1793381039907,"version":"4.5.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1038\/s41584-024-01113-9","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T09:02:28Z","timestamp":1714640548000},"page":"347-360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Relapsing polychondritis: clinical updates and new differential diagnoses"],"prefix":"10.1038","volume":"20","author":[{"given":"Philippe","family":"Mertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela A.","family":"Ferrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Moulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ars\u00e8ne","family":"Mekinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Grayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8077-8394","authenticated-orcid":false,"given":"Laurent","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"1113_CR1","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1007\/s10067-023-06741-2","volume":"42","author":"L Cheng","year":"2023","unstructured":"Cheng, L. et al. Bibliometric analysis of the global publication activity in the field of relapsing polychondritis during 1960\u20132023. Clin. Rheumatol. 42, 3201\u20133212 (2023).","journal-title":"Clin. Rheumatol."},{"key":"1113_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.semarthrit.2011.12.007","volume":"42","author":"SD Mathew","year":"2012","unstructured":"Mathew, S. D., Battafarano, D. F. & Morris, M. J. Relapsing polychondritis in the Department of Defense population and review of the literature. Semin. Arthritis Rheum. 42, 70\u201383 (2012).","journal-title":"Semin. Arthritis Rheum."},{"key":"1113_CR3","first-page":"2181","volume":"54","author":"N Hazra","year":"2015","unstructured":"Hazra, N., Dregan, A., Charlton, J., Gulliford, M. C. & D\u2019Cruz, D. P. Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study. Rheumatology 54, 2181\u20132187 (2015).","journal-title":"Rheumatology"},{"key":"1113_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2147\/CLEP.S91439","volume":"8","author":"A Horv\u00e1th","year":"2016","unstructured":"Horv\u00e1th, A. et al. A nationwide study of the epidemiology of relapsing polychondritis. Clin. Epidemiol. 8, 211\u2013230 (2016).","journal-title":"Clin. Epidemiol."},{"key":"1113_CR5","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jpeds.2009.09.045","volume":"156","author":"A Belot","year":"2010","unstructured":"Belot, A. et al. Pediatric-onset relapsing polychondritis: case series and systematic review. J. Pediatr. 156, 484\u2013489 (2010).","journal-title":"J. Pediatr."},{"key":"1113_CR6","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1080\/14397595.2019.1707995","volume":"30","author":"JT Alqanatish","year":"2020","unstructured":"Alqanatish, J. T. & Alshanwani, J. R. Relapsing polychondritis in children: a review. Mod. Rheumatol. 30, 788\u2013798 (2020).","journal-title":"Mod. Rheumatol."},{"key":"1113_CR7","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1002\/art.39790","volume":"68","author":"J Dion","year":"2016","unstructured":"Dion, J. et al. Relapsing polychondritis can be characterized by three different clinical phenotypes: analysis of a recent series of 142 patients. Arthritis Rheumatol. 68, 2992\u20133001 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1113_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.7326\/0003-4819-129-2-199807150-00011","volume":"129","author":"DE Trentham","year":"1998","unstructured":"Trentham, D. E. & Le, C. H. Relapsing polychondritis. Ann. Intern. Med. 129, 114\u2013122 (1998).","journal-title":"Ann. Intern. Med."},{"key":"1113_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.autrev.2013.07.005","volume":"13","author":"L Arnaud","year":"2014","unstructured":"Arnaud, L., Mathian, A., Haroche, J., Gorochov, G. & Amoura, Z. Pathogenesis of relapsing polychondritis: a 2013 update. Autoimmun. Rev. 13, 90\u201395 (2014).","journal-title":"Autoimmun. Rev."},{"key":"1113_CR10","first-page":"1843","volume":"112","author":"V Taneja","year":"2003","unstructured":"Taneja, V., Griffiths, M., Behrens, M., Luthra, H. S. & David, C. S. Auricular chondritis in NOD.DQ8.A\u03b2o (Ag7\u2212\/\u2212) transgenic mice resembles human relapsing polychondritis. J. Clin. Invest. 112, 1843\u20131850 (2003).","journal-title":"J. Clin. Invest."},{"key":"1113_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/art.1780360513","volume":"36","author":"B Lang","year":"1993","unstructured":"Lang, B. et al. Susceptibility to relapsing polychondritis is associated with HLA-DR4. Arthritis Rheum. 36, 660\u2013664 (1993).","journal-title":"Arthritis Rheum."},{"key":"1113_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/ard-2023-224732","volume":"83","author":"Y Luo","year":"2024","unstructured":"Luo, Y. et al. Ultra-rare genetic variation in relapsing polychondritis: a whole-exome sequencing study.  Ann. Rheum. Dis. 83, 253\u2013260 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"1113_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/1529-0131(200201)46:1<238::AID-ART10030>3.0.CO;2-M","volume":"46","author":"JH Buckner","year":"2002","unstructured":"Buckner, J. H., Van Landeghen, M., Kwok, W. W. & Tsarknaridis, L. Identification of type II collagen peptide 261\u2013273-specific T cell clones in a patient with relapsing polychondritis. Arthritis Rheum. 46, 238\u2013244 (2002).","journal-title":"Arthritis Rheum."},{"key":"1113_CR14","first-page":"2716","volume":"30","author":"J Serratrice","year":"2003","unstructured":"Serratrice, J. et al. Severe relapsing polychondritis occurring after ear piercing. J. Rheumatol. 30, 2716\u20132717 (2003).","journal-title":"J. Rheumatol."},{"key":"1113_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10637-021-01186-3","volume":"40","author":"T Ogimoto","year":"2022","unstructured":"Ogimoto, T., Yoshida, H., Mizuta, M. & Hirai, T. Relapsing polychondritis after treatment with PD-1 blockade. Invest. New Drugs 40, 389\u2013391 (2022).","journal-title":"Invest. New Drugs"},{"key":"1113_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000788","volume":"4","author":"S Rednic","year":"2018","unstructured":"Rednic, S. et al. Relapsing polychondritis: state of the art on clinical practice guidelines. RMD Open\u00a04, e000788 (2018).","journal-title":"RMD Open"},{"key":"1113_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11926-015-0549-5","volume":"18","author":"A Vitale","year":"2016","unstructured":"Vitale, A. et al. Relapsing polychondritis: an update on pathogenesis, clinical features, diagnostic tools, and therapeutic perspectives. Curr. Rheumatol. Rep. 18, 3 (2016).","journal-title":"Curr. Rheumatol. Rep."},{"key":"1113_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.autrev.2012.06.005","volume":"12","author":"L Arnaud","year":"2012","unstructured":"Arnaud, L. et al. The relapsing polychondritis disease activity index: development of a disease activity score for relapsing polychondritis. Autoimmun. Rev. 12, 204\u2013209 (2012).","journal-title":"Autoimmun. Rev."},{"key":"1113_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.revmed.2023.05.005","volume":"44","author":"L Arnaud","year":"2023","unstructured":"Arnaud, L. et al. French practical guidelines for the diagnosis and management of relapsing polychondritis. Rev. Med. Interne 44, 282\u2013294 (2023).","journal-title":"Rev. Med. Interne"},{"key":"1113_CR20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.berh.2016.08.001","volume":"30","author":"A Mathian","year":"2016","unstructured":"Mathian, A. et al. Relapsing polychondritis: a 2016 update on clinical features, diagnostic tools, treatment and biological drug use. Best. Pract. Res. Clin. Rheumatol. 30, 316\u2013333 (2016).","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"1113_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s41927-020-00141-8","volume":"4","author":"J Shimizu","year":"2020","unstructured":"Shimizu, J., Yamano, Y., Kawahata, K. & Suzuki, N. Elucidation of predictors of disease progression in patients with relapsing polychondritis at the onset: potential impact on patient monitoring. BMC Rheumatol. 4, 41 (2020).","journal-title":"BMC Rheumatol."},{"key":"1113_CR22","doi-asserted-by":"publisher","first-page":"00170","DOI":"10.1183\/23120541.00170-2020","volume":"7","author":"S Dubey","year":"2021","unstructured":"Dubey, S. et al. Respiratory subtype of relapsing polychondritis frequently presents as difficult asthma: a descriptive study of respiratory involvement in relapsing polychondritis with 13 patients from a single UK centre. ERJ Open Res. 7, 00170\u201302020 (2021).","journal-title":"ERJ Open Res."},{"key":"1113_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12890-022-01955-7","volume":"22","author":"D Wang","year":"2022","unstructured":"Wang, D., Guan, L., Dong, X., Zhu, X. & Tong, Z. Comparison of relapsing polychondritis patients with and without respiratory involvement based on chest computed tomography: a retrospective cohort study. BMC Pulm. Med. 22, 222 (2022).","journal-title":"BMC Pulm. Med."},{"key":"1113_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13075-022-02935-2","volume":"24","author":"C Jalaber","year":"2022","unstructured":"Jalaber, C. et al. Differentiating tracheobronchial involvement in granulomatosis with polyangiitis and relapsing polychondritis on chest CT: a cohort study. Arthritis Res. Ther. 24, 241 (2022).","journal-title":"Arthritis Res. Ther."},{"key":"1113_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.55563\/clinexprheumatol\/27n7im","volume":"40","author":"L Damian","year":"2022","unstructured":"Damian, L. et al. Rare within rare. Necrotising scleritis and peripheral ulcerative keratitis: eye-threatening complications of relapsing polychondritis. Clin. Exp. Rheumatol. 40, 86\u201392 (2022).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1113_CR26","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1007\/s10792-023-02662-w","volume":"43","author":"K Gallagher","year":"2023","unstructured":"Gallagher, K., Al-Janabi, A. & Wang, A. The ocular manifestations of relapsing polychondritis. Int. Ophthalmol. 43, 2633\u20132641 (2023).","journal-title":"Int. Ophthalmol."},{"key":"1113_CR27","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/art.41270","volume":"72","author":"M Ferrada","year":"2020","unstructured":"Ferrada, M. et al. Defining clinical subgroups in relapsing polychondritis: a prospective observational cohort study. Arthritis Rheumatol. 72, 1396\u20131402 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"1113_CR28","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/lary.23604","volume":"122","author":"MU Malik","year":"2012","unstructured":"Malik, M. U. et al. Spectrum of immune-mediated inner ear disease and cochlear implant results. Laryngoscope 122, 2557\u20132562 (2012).","journal-title":"Laryngoscope"},{"key":"1113_CR29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/rheumatology\/kew065","volume":"55","author":"J Shimizu","year":"2016","unstructured":"Shimizu, J., Oka, H., Yamano, Y., Yudoh, K. & Suzuki, N. Cardiac involvement in relapsing polychondritis in Japan. Rheumatology 55, 583\u2013584 (2016).","journal-title":"Rheumatology"},{"key":"1113_CR30","doi-asserted-by":"publisher","first-page":"1218475","DOI":"10.3389\/fimmu.2023.1218475","volume":"14","author":"R Yin","year":"2023","unstructured":"Yin, R. et al. Relapsing polychondritis: focus on cardiac involvement. Front. Immunol. 14, 1218475 (2023).","journal-title":"Front. Immunol."},{"key":"1113_CR31","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3899\/jrheum.200083","volume":"47","author":"DP D\u2019Cruz","year":"2020","unstructured":"D\u2019Cruz, D. P. & Ferrada, M. A. Relapsing polychondritis and large-vessel vasculitis. J. Rheumatol. 47, 1732\u20131733 (2020).","journal-title":"J. Rheumatol."},{"key":"1113_CR32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jbspin.2017.05.009","volume":"85","author":"M Le Besnerais","year":"2018","unstructured":"Le Besnerais, M. et al. Aortic involvement in relapsing polychondritis. Joint Bone Spine 85, 345\u2013351 (2018).","journal-title":"Joint Bone Spine"},{"key":"1113_CR33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.carpath.2015.05.001","volume":"24","author":"JR Stone","year":"2015","unstructured":"Stone, J. R. et al. Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases. Cardiovasc. Pathol. 24, 267\u2013278 (2015).","journal-title":"Cardiovasc. Pathol."},{"key":"1113_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00005792-200105000-00003","volume":"80","author":"C Franc\u00e8s","year":"2001","unstructured":"Franc\u00e8s, C. et al. Dermatologic manifestations of relapsing polychondritis. A study of 200 cases at a single center. Medicine 80, 173\u2013179 (2001).","journal-title":"Medicine"},{"key":"1113_CR35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/1346-8138.17030","volume":"51","author":"K-R Chen","year":"2023","unstructured":"Chen, K.-R. Cutaneous vasculitis in autoinflammatory diseases. J. Dermatol. 51, 150\u2013159 (2023).","journal-title":"J. Dermatol."},{"key":"1113_CR36","doi-asserted-by":"publisher","first-page":"151924","DOI":"10.1016\/j.semarthrit.2021.10.007","volume":"52","author":"Y Luo","year":"2022","unstructured":"Luo, Y. et al. A prospective observational cohort study and systematic review of 40 patients with mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome. Semin. Arthritis Rheum. 52, 151924 (2022).","journal-title":"Semin. Arthritis Rheum."},{"key":"1113_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2169\/internalmedicine.9411-22","volume":"62","author":"K Yokota","year":"2023","unstructured":"Yokota, K., Tachibana, H., Miyake, A., Yamamoto, T. & Mimura, T. Relapsing polychondritis and aseptic meningoencephalitis. Intern. Med. 62, 481\u2013486 (2023).","journal-title":"Intern. Med."},{"key":"1113_CR38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.31138\/mjr.34.2.229","volume":"34","author":"V Michalaki","year":"2023","unstructured":"Michalaki, V. et al. Limbic encephalitis as a late complication of relapsing polychondritis: a case report and review of the literature. Mediterr. J. Rheumatol. 34, 229\u2013237 (2023).","journal-title":"Mediterr. J. Rheumatol."},{"key":"1113_CR39","doi-asserted-by":"publisher","first-page":"618","DOI":"10.7861\/clinmed.2023-0430","volume":"23","author":"S Husein","year":"2023","unstructured":"Husein, S., Murayama, Y., Koo, A., Wakefield, M. & Buccoliero, R. Relapsing polychondritis presenting with sero-negative limbic encephalitis. Clin. Med. 23, 618\u2013620 (2023).","journal-title":"Clin. Med."},{"key":"1113_CR40","doi-asserted-by":"publisher","first-page":"205873842110005","DOI":"10.1177\/20587384211000547","volume":"35","author":"X Cao","year":"2021","unstructured":"Cao, X. et al. Comparison of relapsing polychondritis patients with and without central nervous system involvement: a retrospective study of 181 patients. Int. J. Immunopathol. Pharmacol. 35, 20587384211000547 (2021).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"1113_CR41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0161-6420(86)33695-9","volume":"93","author":"BL Isaak","year":"1986","unstructured":"Isaak, B. L., Liesegang, T. J. & Michet, C. J. Ocular and systemic findings in relapsing polychondritis. Ophthalmology 93, 681\u2013689 (1986).","journal-title":"Ophthalmology"},{"key":"1113_CR42","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/art.41743","volume":"73","author":"MA Ferrada","year":"2021","unstructured":"Ferrada, M. A. et al. Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS. Arthritis Rheumatol. 73, 1886\u20131895 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"1113_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002255","volume":"8","author":"M-Y Khitri","year":"2022","unstructured":"Khitri, M.-Y. et al. Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients. RMD Open\u00a08, e002255 (2022).","journal-title":"RMD Open"},{"key":"1113_CR44","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1182\/blood.2022016985","volume":"140","author":"MA Ferrada","year":"2022","unstructured":"Ferrada, M. A. et al. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. Blood 140, 1496\u20131506 (2022).","journal-title":"Blood"},{"key":"1113_CR45","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck, D. B. et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N. Engl. J. Med. 383, 2628\u20132638 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1113_CR46","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1136\/ard-2023-224460","volume":"82","author":"JM Mascaro","year":"2023","unstructured":"Mascaro, J. M. et al. Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism. Ann. Rheum. Dis. 82, 1594\u20131605 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1113_CR47","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jama.2022.24836","volume":"329","author":"DB Beck","year":"2023","unstructured":"Beck, D. B. et al. Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population. J. Am. Med. Assoc. 329, 318 (2023).","journal-title":"J. Am. Med. Assoc."},{"key":"1113_CR48","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41584-022-00778-4","volume":"18","author":"DB Beck","year":"2022","unstructured":"Beck, D. B., Werner, A., Kastner, D. L. & Aksentijevich, I. Disorders of ubiquitylation: unchained inflammation. Nat. Rev. Rheumatol. 18, 435\u2013447 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1113_CR49","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41467-024-44811-4","volume":"15","author":"O Kosmider","year":"2024","unstructured":"Kosmider, O. et al. VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation. Nat. Commun.15, 910 (2024).","journal-title":"Nat. Commun."},{"key":"1113_CR50","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1093\/rheumatology\/keab392","volume":"60","author":"T Barba","year":"2021","unstructured":"Barba, T. et al. VEXAS syndrome in a woman. Rheumatology 60, e402\u2013e403 (2021).","journal-title":"Rheumatology"},{"key":"1113_CR51","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3324\/haematol.2021.280238","volume":"107","author":"RJ Stubbins","year":"2022","unstructured":"Stubbins, R. J. et al. VEXAS syndrome in a female patient with constitutional 45, X (Turner syndrome). Haematologica 107, 1011 (2022).","journal-title":"Haematologica"},{"key":"1113_CR52","first-page":"312","volume":"17","author":"J McHugh","year":"2021","unstructured":"McHugh, J. Pathogenic UBA1 variants define a subset of relapsing polychondritis. Nat. Rev. Rheumatol. 17, 312 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1113_CR53","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/annrheumdis-2021-220089","volume":"80","author":"N Tsuchida","year":"2021","unstructured":"Tsuchida, N. et al. Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis. Ann. Rheum. Dis. 80, 1057\u20131061 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"1113_CR54","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1093\/rheumatology\/kead506","volume":"63","author":"BE S\u00e1nchez-Hern\u00e1ndez","year":"2023","unstructured":"S\u00e1nchez-Hern\u00e1ndez, B. E., Calder\u00f3n-Espinoza, I. & Mart\u00edn-Nares, E. Challenging the paradigm: a case of early-onset VEXAS syndrome. Rheumatology 63, e99\u2013e100 (2023).","journal-title":"Rheumatology"},{"key":"1113_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-03003-x","volume":"19","author":"S Duan","year":"2024","unstructured":"Duan, S. et al. Dynamic monitoring of UBA1 somatic mutations in patients with relapsing polychondritis. Orphanet J. Rare Dis. 19, 1 (2024).","journal-title":"Orphanet J. Rare Dis."},{"key":"1113_CR56","first-page":"40","volume":"4","author":"Q Huang","year":"2023","unstructured":"Huang, Q., Cui, D., Chen, J., Ren, H. & Yang, M. Intermittent fever and cough in a 56-year-old patient: relapsing polychondritis and extranodal NK\/T-cell lymphoma. Rheumatol. Immunol. Res. 4, 40\u201343 (2023).","journal-title":"Immunol. Res."},{"key":"1113_CR57","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/00005792-198705000-00004","volume":"66","author":"A Chang-Miller","year":"1987","unstructured":"Chang-Miller, A. et al. Renal involvement in relapsing polychondritis. Medicine 66, 202\u2013217 (1987).","journal-title":"Medicine"},{"key":"1113_CR58","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0002-9343(81)90291-6","volume":"71","author":"LR Espinoza","year":"1981","unstructured":"Espinoza, L. R. et al. Immune complex-mediated renal involvement in relapsing polychondritis. Am. J. Med. 71, 181\u2013183 (1981).","journal-title":"Am. J. Med."},{"key":"1113_CR59","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/ard.52.5.384-b","volume":"52","author":"T Papo","year":"1993","unstructured":"Papo, T. et al. Antineutrophil cytoplasmic antibodies in polychondritis. Ann. Rheum. Dis. 52, 384\u2013385 (1993).","journal-title":"Ann. Rheum. Dis."},{"key":"1113_CR60","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.cell.2018.11.006","volume":"175","author":"J Wolchok","year":"2018","unstructured":"Wolchok, J. Putting the immunologic brakes on cancer. Cell 175, 1452\u20131454 (2018).","journal-title":"Cell"},{"key":"1113_CR61","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian, S. L., Drake, C. G. & Pardoll, D. M. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27, 450\u2013461 (2015).","journal-title":"Cancer Cell"},{"key":"1113_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41416-018-0294-4","volume":"120","author":"L Hirsch","year":"2019","unstructured":"Hirsch, L., Zitvogel, L., Eggermont, A. & Marabelle, A. PD-Loma: a cancer entity with a shared sensitivity to the PD-1\/PD-L1 pathway blockade. Br. J. Cancer 120, 3\u20135 (2019).","journal-title":"Br. J. Cancer"},{"key":"1113_CR63","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow, M. A., Sidlow, R. & Hellmann, M. D. Immune-related adverse events associated with immune checkpoint blockade. N. Engl. J. Med. 378, 158\u2013168 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1113_CR64","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/annrheumdis-2020-217139","volume":"80","author":"M Kostine","year":"2021","unstructured":"Kostine, M. et al. EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors. Ann. Rheum. Dis. 80, 36\u201348 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"1113_CR65","doi-asserted-by":"publisher","first-page":"E43","DOI":"10.1002\/hed.26456","volume":"42","author":"K Kuba","year":"2020","unstructured":"Kuba, K. et al. Nivolumab-related tracheobronchial chondritis: extremely rare manifestation of an immune-related adverse effect. Head Neck 42, E43\u2013E48 (2020).","journal-title":"Head Neck"},{"key":"1113_CR66","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.2169\/internalmedicine.6798-20","volume":"60","author":"T Asoh","year":"2021","unstructured":"Asoh, T., Yanagihara, T., Tanaka, R. & Yoneda, R. Tracheobronchial chondritis associated with immune checkpoint blockade. Intern. Med. 60, 2517\u20132518 (2021).","journal-title":"Intern. Med."},{"key":"1113_CR67","doi-asserted-by":"publisher","unstructured":"Someya, M. et al. Tracheobronchial chondritis as an immune-related adverse event occurring during the administration of nivolumab for recurrent hypopharyngeal squamous cell carcinoma. Ear Nose Throat J. https:\/\/doi.org\/10.1177\/01455613221081912 (2022).","DOI":"10.1177\/01455613221081912"},{"key":"1113_CR68","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/art.42317","volume":"75","author":"K Hamada-Ode","year":"2023","unstructured":"Hamada-Ode, K., Taniguchi, Y., Osaki, M., Yoshimatsu, R. & Nitta, N. Clinical Images: nivolumab-induced tracheobronchial chondritis in a patient with hypopharyngeal cancer. Arthritis Rheumatol. 75, 121 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"1113_CR69","first-page":"552","volume":"6","author":"T Mutoh","year":"2023","unstructured":"Mutoh, T. et al. Relapsing polychondritis following PD-1 blockade by an immune checkpoint inhibitor. JMA J. 6, 552\u2013555 (2023).","journal-title":"JMA J."},{"key":"1113_CR70","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s10067-019-04852-3","volume":"39","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Diagnosing relapsing polychondritis remains a common challenge: experience from a Chinese retrospective cohort. Clin. Rheumatol. 39, 2179\u20132184 (2020).","journal-title":"Clin. Rheumatol."},{"key":"1113_CR71","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00005792-197605000-00001","volume":"55","author":"LP McAdam","year":"1976","unstructured":"McAdam, L. P., O\u2019Hanlan, M. A., Bluestone, R. & Pearson, C. M. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine 55, 193\u2013215 (1976).","journal-title":"Medicine"},{"key":"1113_CR72","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1288\/00005537-197906000-00009","volume":"89","author":"JM Damiani","year":"1979","unstructured":"Damiani, J. M. & Levine, H. L. Relapsing polychondritis \u2014 report of ten cases. Laryngoscope 89, 929\u2013946 (1979).","journal-title":"Laryngoscope"},{"key":"1113_CR73","doi-asserted-by":"publisher","first-page":"74","DOI":"10.7326\/0003-4819-104-1-74","volume":"104","author":"CJ Michet","year":"1986","unstructured":"Michet, C. J., McKenna, C. H., Luthra, H. S. & O\u2019Fallon, W. M. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann. Intern. Med. 104, 74\u201378 (1986).","journal-title":"Ann. Intern. Med."},{"key":"1113_CR74","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1056\/NEJM197811302992202","volume":"299","author":"JM Foidart","year":"1978","unstructured":"Foidart, J. M. et al. Antibodies to type II collagen in relapsing polychondritis. N. Engl. J. Med. 299, 1203\u20131207 (1978).","journal-title":"N. Engl. J. Med."},{"key":"1113_CR75","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/1529-0131(200004)43:4<939::AID-ANR28>3.0.CO;2-Z","volume":"43","author":"JH Buckner","year":"2000","unstructured":"Buckner, J. H., Wu, J. J., Reife, R. A., Terato, K. & Eyre, D. R. Autoreactivity against matrilin-1 in a patient with relapsing polychondritis. Arthritis Rheum. 43, 939\u2013943 (2000).","journal-title":"Arthritis Rheum."},{"key":"1113_CR76","first-page":"553","volume":"28","author":"F Kempta Lekpa","year":"2010","unstructured":"Kempta Lekpa, F. et al. Serum cartilage oligomeric matrix protein (COMP) level is a marker of disease activity in relapsing polychondritis. Clin. Exp. Rheumatol. 28, 553\u2013555 (2010).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1113_CR77","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1053\/j.seminhematol.2021.10.007","volume":"58","author":"N Patel","year":"2021","unstructured":"Patel, N., Dulau-Florea, A. & Calvo, K. R. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome. Semin. Hematol. 58, 204\u2013211 (2021).","journal-title":"Semin. Hematol."},{"key":"1113_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0542-8","volume":"11","author":"M Finetti","year":"2016","unstructured":"Finetti, M., Omenetti, A., Federici, S., Caorsi, R. & Gattorno, M. Chronic infantile neurological cutaneous and articular (CINCA) syndrome: a review. Orphanet J. Rare Dis. 11, 167 (2016).","journal-title":"Orphanet J. Rare Dis."},{"key":"1113_CR79","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/art.38008","volume":"65","author":"A Belot","year":"2013","unstructured":"Belot, A. et al. Protein kinase c\u03b4 deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. Arthritis Rheum. 65, 2161\u20132171 (2013).","journal-title":"Arthritis Rheum."},{"key":"1113_CR80","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1182\/blood-2010-02-267583","volume":"116","author":"SS De Ravin","year":"2010","unstructured":"De Ravin, S. S. et al. Hypomorphic Rag mutations can cause destructive midline granulomatous disease. Blood 116, 1263\u20131271 (2010).","journal-title":"Blood"},{"key":"1113_CR81","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/qjmed\/hci112","volume":"98","author":"J Zimmer","year":"2005","unstructured":"Zimmer, J. et al. Clinical and immunological aspects of HLA class I deficiency. QJM 98, 719\u2013727 (2005).","journal-title":"QJM"},{"key":"1113_CR82","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jamadermatol.2015.0251","volume":"151","author":"J Munoz","year":"2015","unstructured":"Munoz, J. et al. Stimulator of interferon genes-associated vasculopathy with onset in infancy: a mimic of childhood granulomatosis with polyangiitis. JAMA Dermatol. 151, 872\u2013877 (2015).","journal-title":"JAMA Dermatol."},{"key":"1113_CR83","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1312625","volume":"371","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Activated STING in a vascular and pulmonary syndrome. N. Engl. J. Med. 371, 507\u2013518 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1113_CR84","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1086\/513443","volume":"80","author":"G Rice","year":"2007","unstructured":"Rice, G. et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am. J. Hum. Genet. 80, 811\u2013815 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"1113_CR85","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10875-022-01344-z","volume":"43","author":"RTA van Wijck","year":"2023","unstructured":"van Wijck, R. T. A., Swagemakers, S. M. A., van der Spek, P. J., van Hagen, P. M. & van Daele, P. L. A. A CDC42 stop-loss mutation in a patient with relapsing polychondritis and autoinflammation. J. Clin. Immunol. 43, 69\u201371 (2023).","journal-title":"J. Clin. Immunol."},{"key":"1113_CR86","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41577-021-00500-7","volume":"21","author":"R El Masri","year":"2021","unstructured":"El Masri, R. & Delon, J. RHO GTPases: from new partners to complex immune syndromes. Nat. Rev. Immunol. 21, 499\u2013513 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1113_CR87","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1002\/ajmg.a.37275","volume":"167A","author":"T Takenouchi","year":"2015","unstructured":"Takenouchi, T., Kosaki, R., Niizuma, T., Hata, K. & Kosaki, K. Macrothrombocytopenia and developmental delay with a de novo CDC42 mutation: yet another locus for thrombocytopenia and developmental delay. Am. J. Med. Genet. A 167A, 2822\u20132825 (2015).","journal-title":"Am. J. Med. Genet. A"},{"key":"1113_CR88","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1084\/jem.20190147","volume":"216","author":"MT Lam","year":"2019","unstructured":"Lam, M. T. et al. A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function. J. Exp. Med. 216, 2778\u20132799 (2019).","journal-title":"J. Exp. Med."},{"key":"1113_CR89","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.jaci.2019.06.017","volume":"144","author":"Y Gernez","year":"2019","unstructured":"Gernez, Y. et al. Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1\u03b2 inhibition. J. Allergy Clin. Immunol. 144, 1122\u20131125.e6 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1113_CR90","doi-asserted-by":"publisher","first-page":"102353","DOI":"10.1016\/j.autrev.2019.102353","volume":"18","author":"N de Montmollin","year":"2019","unstructured":"de Montmollin, N. et al. Tracheobronchial involvement of relapsing polychondritis. Autoimmun. Rev. 18, 102353 (2019).","journal-title":"Autoimmun. Rev."},{"key":"1113_CR91","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1148\/radiol.2401050562","volume":"240","author":"KS Lee","year":"2006","unstructured":"Lee, K. S. et al. Relapsing polychondritis: prevalence of expiratory CT airway abnormalities. Radiology 240, 565\u2013573 (2006).","journal-title":"Radiology"},{"key":"1113_CR92","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1378\/chest.124.6.2393","volume":"124","author":"Y Miyazu","year":"2003","unstructured":"Miyazu, Y. et al. Endobronchial ultrasonography in the diagnosis and treatment of relapsing polychondritis with tracheobronchial malacia. Chest 124, 2393\u20132395 (2003).","journal-title":"Chest"},{"key":"1113_CR93","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.21037\/atm-21-6175","volume":"9","author":"J Tang","year":"2021","unstructured":"Tang, J. et al. Extracorporeal high-frequency combined with contrast-enhanced ultrasound: a novel imaging method for detection and treatment evaluation of patients with cervical trachea-associated relapsing polychondritis. Ann. Transl. Med. 9, 1785 (2021).","journal-title":"Ann. Transl. Med."},{"key":"1113_CR94","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1097\/RHU.0000000000001264","volume":"27","author":"R Sato","year":"2021","unstructured":"Sato, R. et al. Advantage of magnetic resonance imaging in detecting tracheal involvement and evaluation of the therapeutic response in relapsing polychondritis with asthma-like symptoms. J. Clin. Rheumatol. 27, e90\u2013e91 (2021).","journal-title":"J. Clin. Rheumatol."},{"key":"1113_CR95","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/rheumatology\/kez243","volume":"59","author":"A Sharma","year":"2020","unstructured":"Sharma, A. et al. Fluorodeoxyglucose positron emission tomography\/computed tomography in the diagnosis, assessment of disease activity and therapeutic response in relapsing polychondritis. Rheumatology 59, 99\u2013106 (2020).","journal-title":"Rheumatology"},{"key":"1113_CR96","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3390\/life11090956","volume":"11","author":"S Okuda","year":"2021","unstructured":"Okuda, S. et al. FDG-PET\/CT and auricular cartilage biopsy are useful for diagnosing with relapsing polychondritis in patients without auricular symptoms. Life 11, 956 (2021).","journal-title":"Life"},{"key":"1113_CR97","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/03009742.2022.2103937","volume":"52","author":"D Nakatsubo","year":"2023","unstructured":"Nakatsubo, D. et al. A case of relapsing polychondritis localized to the laryngeal cartilage in which FDG-PET\/CT was helpful for diagnosis. Scand. J. Rheumatol. 52, 102\u2013104 (2023).","journal-title":"Scand. J. Rheumatol."},{"key":"1113_CR98","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s13075-019-2083-8","volume":"21","author":"Y Zeng","year":"2019","unstructured":"Zeng, Y. et al. Is 18F-FDG PET\/CT useful for diagnosing relapsing polychondritis with airway involvement and monitoring response to steroid-based therapy? Arthritis Res. Ther. 21, 282 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"1113_CR99","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/1756-185X.14256","volume":"25","author":"M Yoshida","year":"2022","unstructured":"Yoshida, M., Taniguchi, Y., Yoshida, T., Nishikawa, H. & Terada, Y. Ultrasonography of auricular cartilage is a potential tool for diagnosing relapsing polychondritis and monitoring disease activity. Int. J. Rheum. Dis. 25, 201\u2013209 (2022).","journal-title":"Int. J. Rheum. Dis."},{"key":"1113_CR100","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/bjh.18220","volume":"198","author":"Y Dawudi","year":"2022","unstructured":"Dawudi, Y. et al. B-cell lymphoma mimicking relapsing polychondritis. Br. J. Haematol. 198, 222 (2022).","journal-title":"Br. J. Haematol."},{"key":"1113_CR101","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/acr.24574","volume":"74","author":"E Rose","year":"2022","unstructured":"Rose, E. et al. Physician global assessment as a disease activity measure for relapsing polychondritis. Arthritis Care Res. 74, 1269\u20131276 (2022).","journal-title":"Arthritis Care Res."},{"key":"1113_CR102","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1093\/rheumatology\/keab587","volume":"61","author":"E Rose","year":"2022","unstructured":"Rose, E. et al. Discordance in patient and physician global assessment in relapsing polychondritis. Rheumatology 61, 2025\u20132033 (2022).","journal-title":"Rheumatology"},{"key":"1113_CR103","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1007\/s10067-021-05827-z","volume":"40","author":"X Cao","year":"2021","unstructured":"Cao, X. et al. Three new inflammatory markers C reactive protein to albumin ratio, neutrophil to lymphocyte ratio, and platelet to lymphocyte ratio correlated with relapsing polychondritis disease activity index. Clin. Rheumatol. 40, 4685\u20134691 (2021).","journal-title":"Clin. Rheumatol."},{"key":"1113_CR104","doi-asserted-by":"publisher","first-page":"1274677","DOI":"10.3389\/fimmu.2023.1274677","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Development and validation of diagnostic and activity-assessing models for relapsing polychondritis based on laboratory parameters. Front. Immunol. 14, 1274677 (2023).","journal-title":"Front. Immunol."},{"key":"1113_CR105","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jbspin.2018.11.001","volume":"86","author":"P Mertz","year":"2019","unstructured":"Mertz, P. et al. The relapsing polychondritis damage index (RPDAM): development of a disease-specific damage score for relapsing polychondritis. Joint Bone Spine 86, 363\u2013368 (2019).","journal-title":"Joint Bone Spine"},{"key":"1113_CR106","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1017\/S002221512200038X","volume":"137","author":"S-Y Zhai","year":"2023","unstructured":"Zhai, S.-Y. et al. Clinical analysis of relapsing polychondritis with airway involvement. J. Laryngol. Otol. 137, 96\u2013100 (2023).","journal-title":"J. Laryngol. Otol."},{"key":"1113_CR107","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13075-022-02810-0","volume":"24","author":"T Yoshida","year":"2022","unstructured":"Yoshida, T. et al. Risk factors for the recurrence of relapsing polychondritis. Arthritis Res. Ther. 24, 127 (2022).","journal-title":"Arthritis Res. Ther."},{"key":"1113_CR108","first-page":"1245","volume":"40","author":"T Papo","year":"1997","unstructured":"Papo, T. et al. Pregnancy in relapsing polychondritis: twenty-five pregnancies in eleven patients. Arthritis Rheum. 40, 1245\u20131249 (1997).","journal-title":"Arthritis Rheum."},{"key":"1113_CR109","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.3899\/jrheum.210062","volume":"48","author":"N Chen","year":"2021","unstructured":"Chen, N. & Zheng, Y. Characteristics and clinical outcomes of 295 patients with relapsing polychondritis. J. Rheumatol. 48, 1876\u20131882 (2021).","journal-title":"J. Rheumatol."},{"key":"1113_CR110","doi-asserted-by":"publisher","first-page":"103352","DOI":"10.1016\/j.autrev.2023.103352","volume":"22","author":"SR Sangle","year":"2023","unstructured":"Sangle, S. R. et al. Relapsing polychondritis \u2014 a single centre study in the United Kingdom. Autoimmun. Rev. 22, 103352 (2023).","journal-title":"Autoimmun. Rev."},{"key":"1113_CR111","doi-asserted-by":"publisher","first-page":"81","DOI":"10.55563\/clinexprheumatol\/h9gq1o","volume":"40","author":"A Petitdemange","year":"2022","unstructured":"Petitdemange, A. et al. Treatment of relapsing polychondritis: a systematic review. Clin. Exp. Rheumatol. 40, 81\u201385 (2022).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1113_CR112","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-252431","volume":"15","author":"T Yoshida","year":"2022","unstructured":"Yoshida, T., Nishimura, K., Murabe, H. & Yokota, T. Dapsone-induced methaemoglobinaemia in relapsing polychondritis. BMJ Case Rep. 15, e252431 (2022).","journal-title":"BMJ Case Rep."},{"key":"1113_CR113","first-page":"1172","volume":"77","author":"G Moulis","year":"2018","unstructured":"Moulis, G. et al. Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study. Ann. Rheum. Dis. 77, 1172\u20131178 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"1113_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35616-4","volume":"13","author":"H Handa","year":"2023","unstructured":"Handa, H., Ooka, S., Shimizu, J., Suzuki, N. & Mineshita, M. Evaluation of airway involvement and treatment in patients with relapsing polychondritis. Sci. Rep. 13, 8307 (2023).","journal-title":"Sci. Rep."},{"key":"1113_CR115","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/blood.2022016642","volume":"140","author":"M Heiblig","year":"2022","unstructured":"Heiblig, M. et al. Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study. Blood 140, 927\u2013931 (2022).","journal-title":"Blood"},{"key":"1113_CR116","doi-asserted-by":"publisher","first-page":"930071","DOI":"10.3389\/fmed.2022.930071","volume":"9","author":"Z Boyadzhieva","year":"2022","unstructured":"Boyadzhieva, Z., Ruffer, N., Burmester, G., Pankow, A. & Krusche, M. Effectiveness and safety of JAK inhibitors in autoinflammatory diseases: a systematic review. Front. Med. 9, 930071 (2022).","journal-title":"Front. Med."},{"key":"1113_CR117","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1093\/rheumatology\/kead240","volume":"62","author":"Z Boyadzhieva","year":"2023","unstructured":"Boyadzhieva, Z., Ruffer, N., K\u00f6tter, I. & Krusche, M. How to treat VEXAS syndrome: a systematic review on effectiveness and safety of current treatment strategies. Rheumatology 62, 3518\u20133525 (2023).","journal-title":"Rheumatology"},{"key":"1113_CR118","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1136\/annrheumdis-2021-220876","volume":"80","author":"Y Kirino","year":"2021","unstructured":"Kirino, Y. et al. Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan. Ann. Rheum. Dis. 80, 1501\u20131502 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"1113_CR119","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jdcr.2022.02.022","volume":"23","author":"A Goyal","year":"2022","unstructured":"Goyal, A. et al. Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome. JAAD Case Rep. 23, 15\u201319 (2022).","journal-title":"JAAD Case Rep."},{"key":"1113_CR120","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/bjh.17893","volume":"196","author":"T Comont","year":"2022","unstructured":"Comont, T. et al. Azacitidine for patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry. Br. J. Haematol. 196, 969\u2013974 (2022).","journal-title":"Br. J. Haematol."},{"key":"1113_CR121","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1017\/S0022215113001746","volume":"127","author":"C Xie","year":"2013","unstructured":"Xie, C., Shah, N., Shah, P. L. & Sandhu, G. Laryngotracheal reconstruction for relapsing polychondritis: case report and review of the literature. J. Laryngol. Otol. 127, 932\u2013935 (2013).","journal-title":"J. Laryngol. Otol."},{"key":"1113_CR122","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1001\/jamaoto.2022.3782","volume":"149","author":"JW Lee","year":"2023","unstructured":"Lee, J. W. et al. Auricular reconstruction for bilateral auricular deformity caused by relapsing polychondritis. JAMA Otolaryngol. Head Neck Surg. 149, 94\u201395 (2023).","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"1113_CR123","first-page":"247","volume":"298","author":"MT Khayyal","year":"1989","unstructured":"Khayyal, M. T. et al. Radiation exposure and the effect of piroxicam and diclofenac on mediator release from isolated guinea-pig lung. Arch. Int. Pharmacodyn. Ther. 298, 247\u2013263 (1989).","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"1113_CR124","doi-asserted-by":"publisher","first-page":"772","DOI":"10.4065\/81.6.772","volume":"81","author":"C Dib","year":"2006","unstructured":"Dib, C. et al. Surgical treatment of the cardiac manifestations of relapsing polychondritis: overview of 33 patients identified through literature review and the Mayo Clinic records. Mayo Clin. Proc. 81, 772\u2013776 (2006).","journal-title":"Mayo Clin. Proc."},{"key":"1113_CR125","doi-asserted-by":"publisher","unstructured":"Arashi, K. et al. Bilateral deafness due to relapsing polychondritis with semicircular canal calcification treated with cochlear implantation: a case report. Ear Nose Throat J. https:\/\/doi.org\/10.1177\/01455613231215173 (2023).","DOI":"10.1177\/01455613231215173"},{"key":"1113_CR126","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00101-023-01265-5","volume":"72","author":"Y Peng","year":"2023","unstructured":"Peng, Y., Ni, N. & Jiang, Z. Collapse crisis of tracheomalacia caused by undiagnosed relapsing polychondritis during general anesthesia: a case report. Anaesthesiologie 72, 36\u201338 (2023).","journal-title":"Anaesthesiologie"},{"key":"1113_CR127","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1002\/acr.23492","volume":"70","author":"MA Ferrada","year":"2018","unstructured":"Ferrada, M. A. et al. Patient perception of disease-related symptoms and complications in relapsing polychondritis. Arthritis Care Res. 70, 1124\u20131131 (2018).","journal-title":"Arthritis Care Res."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01113-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01113-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T09:04:54Z","timestamp":1716973494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01113-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":127,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1113"],"URL":"https:\/\/doi.org\/10.1038\/s41584-024-01113-9","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"27 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.M. has received research grants from Amgen, Grifols, Novartis and Sanofi, and is on the advisory board for Amgen, Argenx, Grifols, Novartis, Sanofi and Sobi.\u00a0The other authors\u00a0declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}